Initiation and Continuation of Sodium-Glucose Cotransporter 2 Inhibitors in Hospital Inpatients: Ready for Prime Time?
- PMID: 36455120
- DOI: 10.2337/dci22-0039
Initiation and Continuation of Sodium-Glucose Cotransporter 2 Inhibitors in Hospital Inpatients: Ready for Prime Time?
Comment on
-
Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19.Diabetes Care. 2022 Sep 8:dc220357. doi: 10.2337/dc22-0357. Online ahead of print. Diabetes Care. 2022. PMID: 36074663